Blackstone Inc’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-400,000
Closed -$8.56M 551
2021
Q4
$8.56M Sell
400,000
-600,000
-60% -$11.8M 0.02% 146
2021
Q3
$18.5M Buy
+1,000,000
New +$20.1M 0.04% 107

Other funds holding OCDX

Blackstone Inc's OCDX Position: Q1 2022 in Review

Blackstone Inc sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 400,000 shares — an estimated $8.56M sold.

Blackstone Inc first reported a position in OCDX in Q3 2021 and held it in 2 quarters. The position peaked at $18.5M in Q3 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Blackstone Inc reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Blackstone Inc sold 400,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $8.56M.
  • Blackstone Inc first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 2 quarters.
  • Blackstone Inc's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $18.5M in Q3 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Blackstone Inc's 13F filing for Q1 2022, filed 16 May 2022.